Comera Life Sciences Holdings Earnings & Revenue FAQ
What were CMRA's earnings last quarter?
Comera Life Sciences Holdings (NASDAQ: CMRA) reported Q2 2023 earnings per share (EPS) of -$0.08, up 92.98% year over year. Total Comera Life Sciences Holdings earnings for the quarter were -$1.50 million. In the same quarter last year, Comera Life Sciences Holdings's earnings per share (EPS) was -$1.14.
As of Q3 2023, Comera Life Sciences Holdings's earnings has grown year over year. Comera Life Sciences Holdings's earnings in the past year totalled -$10.28 million.
What was CMRA's revenue last quarter?
Comera Life Sciences Holdings (NASDAQ: CMRA) reported Q2 2023 revenue of $315.06 thousand up 114.72% year over year. In the same quarter last year, Comera Life Sciences Holdings's revenue was $146.73 thousand.
What was CMRA's revenue growth in the past year?
As of Q3 2023, Comera Life Sciences Holdings's revenue has grown 172.6% year over year. This is 73.1 percentage points higher than the US Biotechnology industry revenue growth rate of 99.5%. Comera Life Sciences Holdings's revenue in the past year totalled $1.10 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.